Targeted nanoscale therapeutics for myocardial infarction-Reference-Cited by-同舟云学术

Targeted nanoscale therapeutics for myocardial infarction

Published:2021 Issue:4 Volume:9 Page:1204-1216
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Sullivan Holly L.¹²³⁴⁵,Gianneschi Nathan C.⁶⁷⁸⁹¹⁰^ORCID,Christman Karen L.¹²³⁴⁵^ORCID

Affiliation:

1. Department of Bioengineering and Sanford Consortium for Regenerative

2. Medicine

3. University of California

4. San Diego

5. La Jolla

6. Department of Chemistry

7. Department of Materials Science and Engineering

8. Department of Biomedical Engineering

9. Department of Pharmacology

10. International Institute for Nanotechnology

Abstract

Nanoscale therapeutics have promise for enabling targeted administration of therapeutic small molecules and biologics to the heart following myocardial infarction.

Funder

National Heart, Lung, and Blood Institute

National Institutes of Health

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2021/BM/D0BM01677B

Reference90 articles.

1. Ventricular Septal Rupture after Acute Myocardial Infarction

2. Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry

3. Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention

4. Ventricular septal and free wall rupture complicating acute myocardial infarction: Experience in the Multicenter Investigation of Limitation of Infarct Size

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhalable cardiac targeting peptide modified nanomedicine prevents pressure overload heart failure in male mice;Nature Communications;2024-07-18

2. RGD-modified ZIF-8 nanoparticles as a drug carrier for MR imaging and targeted drug delivery in myocardial infarction;Nanomedicine;2024-07-16

3. Intravascularly Deliverable Biomaterial Platforms for Tissue Repair and Regeneration Post‐Myocardial Infarction;Advanced Materials;2023-10-29

4. Enzyme-Responsive Nanoparticles for the Targeted Delivery of an MMP Inhibitor to Acute Myocardial Infarction;Biomacromolecules;2023-09-11

5. VEGF mimetic peptide-conjugated nanoparticles for magnetic resonance imaging and therapy of myocardial infarction;Journal of Controlled Release;2023-08